Form 424B5 PROCEPT BioRobotics Corp

Go back to Form 424B5 PROCEPT BioRobotics Corp

BTIG Reiterates Neutral Rating on Procept BioRobotics Corp (PRCT)

October 29, 2024 5:49 AM EDT

BTIG analyst Ryan Zimmerman reiterated a Neutral rating on Procept BioRobotics Corp (NASDAQ: PRCT).

The analyst comments "We maintain our Neutral on PRCT shares following 3Q24 results. PRCT has been a battleground stock for multiple quarters now and despite our caution into 3Q24 from a host of dynamics (IV fluid availability, commercial and CMS... More